This article reports that Morgan Stanley has increased its price target for Cardinal Health, Inc. (CAH) following the company’s strong performance in the second quarter. The revised price target reflects an optimistic outlook on CAH’s future financial results and market position.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Morgan Stanley raises Cardinal Health, Inc. (CAH) price target after strong Q2
This article reports that Morgan Stanley has increased its price target for Cardinal Health, Inc. (CAH) following the company’s strong performance in the second quarter. The revised price target reflects an optimistic outlook on CAH’s future financial results and market position.